newsfilter
← Latest News
PR Newswire·

Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and...